Feedback / Questions
mipasetamab uzoptirine (ADCT-601) - Overland ADCT BioPharma
ADCT-701 - ADC Therapeutics
ADCT-901 - Overland ADCT BioPharma
https://www.businesswire.com/news/home/20220208005336/en/ADC-Therapeutics-Highlights-its-Proprietary-ADC-Platform-and-Solid-Tumor-Pipeline
Feb 8, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next